201 related articles for article (PubMed ID: 15195245)
21. Varicella-zoster virus infection of a human CD4-positive T-cell line.
Zerboni L; Sommer M; Ware CF; Arvin AM
Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
[TBL] [Abstract][Full Text] [Related]
22. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
23. Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox.
Vossen MT; Gent MR; Peters KM; Wertheim-van Dillen PM; Dolman KM; van Breda A; van Lier RA; Kuijpers TW
J Clin Microbiol; 2005 Nov; 43(11):5614-21. PubMed ID: 16272494
[TBL] [Abstract][Full Text] [Related]
24. Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.
Baiker A; Haase R; Eberle J; Vizoso Pinto MG; Pfrepper KI; Petrich A; Deml L; Campe H; Nitschko H; Jaeger G
Virol J; 2010 Mar; 7():54. PubMed ID: 20205920
[TBL] [Abstract][Full Text] [Related]
25. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
[TBL] [Abstract][Full Text] [Related]
26. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
27. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.
Smith JG; Liu X; Kaufhold RM; Clair J; Caulfield MJ
Clin Diagn Lab Immunol; 2001 Sep; 8(5):871-9. PubMed ID: 11527795
[TBL] [Abstract][Full Text] [Related]
30. Antigen-specific T-cell immunity in multiple myeloma patients is restored following high-dose therapy: implications for timing of vaccination.
Svane IM; Nikolajsen K; Johnsen HE
Scand J Immunol; 2007 Oct; 66(4):465-75. PubMed ID: 17850592
[TBL] [Abstract][Full Text] [Related]
31. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
[TBL] [Abstract][Full Text] [Related]
32. Isolation of varicella-zoster virus from vesicles in children with varicella.
Ozaki T; Kajita Y; Namazue J; Yamanishi K
J Med Virol; 1996 Apr; 48(4):326-8. PubMed ID: 8699164
[TBL] [Abstract][Full Text] [Related]
33. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
34. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.
Smith JG; Levin M; Vessey R; Chan IS; Hayward AR; Liu X; Kaufhold RM; Clair J; Chalikonda I; Chan C; Bernard M; Wang WW; Keller P; Caulfield MJ
J Med Virol; 2003; 70 Suppl 1():S38-41. PubMed ID: 12627485
[TBL] [Abstract][Full Text] [Related]
35. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
Li L; Lao SH; Wu CY
Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
[TBL] [Abstract][Full Text] [Related]
36. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
37. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
[TBL] [Abstract][Full Text] [Related]
38. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
39. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
Nyerges G; Mészner Z; Simon M
Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
